Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

NCT06043921 is registered in ClinicalTrials.gov with Invitae Corporation as lead sponsor.

NCT NCT06043921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06043921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
Lead sponsor
Invitae Corporation
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2022
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer